Key facts
- It has raised $4.8M; the latest was Accelerator/Incubator in Aug 2025.
- Notable investors include Impact Assets, DeveloPPP Ventures, MIT Solve, African Union Development Agency-NEPAD, Johnson & Johnson Services — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Rology
- ·The full record, as it builds
Funding rounds
No funding rounds for Rology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rology
Developer of an FDA-cleared AI-assisted teleradiology platform designed to improve diagnostic imaging and streamline access to high-quality radiology reporting. The company offers integration with hospital systems, a network of sub-specialized radiologists, and multiple AI models, enabling healthcare providers across the Middle East and Africa, faster reporting, greater accuracy, and reduced operational costs.
- Sector
- Healthcare
- HQ
- Cairo, Egypt
- Founded
- 2017
- Employees
- 60
- Website
- rology.health/
- Ownership
- Privately Held (backing)
Rology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rology in its N-PORT filings yet. We sweep new filings monthly.